SPHK1 expression was significantly increased in ovarian cancer compared to OSE and FT (Figure 4A, ****p < 0.0001) and in metastatic tissues compared to FT (Figure 4A, **p = 0.0013). This evidence concerns the gene SPHK1 and ovarian carcinoma.